Skip to main content

Marina Tarrés Mercader

Institutions of which they are part

Research technician
Gene Therapy at Nervous System
Vall Hebron Institut de Recerca

Marina Tarrés Mercader

Institutions of which they are part

Research technician
Gene Therapy at Nervous System
Vall Hebron Institut de Recerca

Projects

ESTUDIO Y DESARROLLO DE LA PRIMERA PLATAFORMA TECNOLÓGICA DE ENSAYOS PARA VIRUS ADENOASOCIADOS EN TERÁPIA GÉNICA

IP: Miguel Chillon Rodriguez
Collaborators: Susana Miravet Delgado, Laia Rubio Ortega, Marina Tarrés Mercader, Almudena Sanchez Garcia
Funding agency: Instituto de Salud Carlos III
Funding: 296571
Reference: PMPTA22/00048
Duration: 01/01/2023 - 30/06/2025

Related news

The treatment, licensed to Klotho Neurosciences, is based on a technology developed at the Universitat Autònoma de Barcelona (UAB) with the participation of VHIR.

The European Rare Diseases Research Alliance (ERDERA) kicked off this September, with an estimated budget of 380 million euros and the aim of improving the lives of 30 million rare disease patients in Europe and beyond.

This gene therapy protects mice against cognitive deficits associated with aging, improves motor function, and delays the onset of diseases such as amyotrophic lateral sclerosis (ALS) and Alzheimer’s disease.

Related professionals

Alicia Fresno González

Alicia Fresno González

Administration and Management
Cardiovascular Diseases
Read more
Silvia Serres Soler

Silvia Serres Soler

Tècnic/a Grau Superior
Unitat legal
Legal Directorate
Read more
Maria Pallares Masmitja

Maria Pallares Masmitja

Postdoctoral researcher
Gene Therapy at Nervous System
Read more
Nuria Gonzalez Llorens

Nuria Gonzalez Llorens

Growth and Development
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.